Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,922.42 billion, total revenue of $603.35 billion and a weighted average PE ratio of 33.93.

Market Cap

2,922.42B

Revenue

603.35B

Profits

86.13B

PE Ratio

33.93

Profit Margin

14.28%

Dividend Yield

2.06%

18 Stocks

No.	Symbol	Company Name	Market Cap	% Change	Volume	Revenue
1	LLY	Eli Lilly and Company	731.71B	-0.15%	1,041,553	35.93B
2	JNJ	Johnson & Johnson	372.19B	0.23%	3,830,481	81.80B
3	MRK	Merck & Co., Inc.	332.08B	0.24%	3,630,348	61.40B
4	ABBV	AbbVie Inc.	293.68B	1.26%	2,961,276	54.40B
5	AZN	AstraZeneca PLC	238.44B	-0.18%	2,280,787	47.61B
6	NVS	Novartis AG	200.81B	-0.12%	571,313	49.92B
7	AMGN	Amgen Inc.	167.32B	-0.71%	1,431,985	29.53B
8	PFE	Pfizer Inc.	162.15B	-0.97%	19,884,267	55.09B
9	SNY	Sanofi	112.48B	-0.31%	513,920	51.60B
10	GSK	GSK plc	91.81B	0.22%	1,547,525	39.41B
11	BMY	Bristol-Myers Squibb Company	89.22B	-0.18%	9,675,808	45.53B
12	GILD	Gilead Sciences, Inc.	84.24B	-0.21%	2,356,642	27.45B
13	BIIB	Biogen Inc.	33.53B	0.23%	703,078	9.66B
14	GRFS	Grifols, S.A.	6.60B	0.39%	928,483	7.32B
15	OGN	Organon & Co.	5.62B	1.30%	1,315,795	6.35B
16	AMRN	Amarin Corporation plc	358.53M	-4.65%	891,234	277.46M
17	SCLX	Scilex Holding Company	162.51M	3.45%	961,190	47.05M
18	MIRA	MIRA Pharmaceuticals, Inc.	9.61M	-4.34%	70,704	-